Navigation Links
BioElectronics' Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
Date:4/25/2012

FREDERICK, Md., April 25, 2012 /PRNewswire/ -- BioElectronics Corporation (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced the results of a customer survey.  The results indicate that patients using BIEL's ActiPatch® therapy report a five-fold greater pain reduction than those using non-steroidal anti-inflammatory products such as ibuprofen and aspirin.

ActiPatch Therapy, which uses pulsed shortwave therapy based on large expensive machines used in clinics and hospitals, was most frequently used to treat lower back pain by participants in the survey.  Lower back pain is a major health problem in western industrialized countries and a major cause of medical expenses and disablement.

"The most widely used OTC drugs have a significant number of side effects, are minimally effective and have only short-term symptomatic relief," said Ian Rawe, Ph.D., BioElectronics Director of Clinical Research. "In comparison, ActiPatch users who participated in the survey had a five-fold greater pain reduction than persons using non-steroidal anti-inflammatory drugs, based on a comparison to published clinical data. Additionally, with ActiPatch's all-day safe pain relief, people can resume their normal daily activities."

"We are very pleased by the results of our consumer survey, which confirms our clinical studies in which ActiPatch users as compared to users of OTC pain medications, have greater pain relief and an improved quality of life," Dr. Rawe said. "An increased consumer awareness of the dangers of overuse of oral analgesics such as acetaminophen and non-steroidal anti-inflammatory drugs has significantly altered the competitive landscape for pain management therapeutics. There is significant need for an improved efficacy, competitively priced over-the-counter therapeutic agent with no side-effects."

Results of the survey, which also show that patients would recommend ActiPatch® to a friend and would themselves purchase another ActiPatch® if the need arose, can be viewed at: www.bielcorp.com/survey.

About BioElectronics Corporation

BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care method to reduce soft tissue pain and swelling. For more information, please visit www.bielcorp.com.

Contact:  E & E Communications
Paul Knopick
(949) 707-5365


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
2. BioElectronics Corporation to Webcast, Live, at RetailInvestorConferences.com on October 6th
3. YesDTC Holdings and BioElectronics Receive Japanese Regulatory Review Date
4. BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date
5. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
6. BioElectronics Announces Major Clinical Trials
7. KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard
8. Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation
9. New Survey: Walgreens Customers Flock to Independent Pharmacies
10. PAREXEL Global Survey Results Identify Top Concerns of Biopharma Industry in Achieving Commercial Success
11. Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... PARK, Calif. , Oct. 11, 2017  BioPharmX ... national scientific team that developed an innovative way to ... quantity of the delivery of new drugs. ... 2017 Fall Clinical Dermatology Conference will show how researchers ... General Hospital, Harvard Medical School used a suite of ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
Breaking Medicine Technology:
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):